|
1. |
Use of CA 19-9 in the Early Detection of Recurrences in Colorectal Cancer: Comparison with CEA |
|
Tumor Biology,
Volume 15,
Issue 1,
1994,
Page 1-6
X. Filella,
R. Molina,
J.M. Piqué,
J.C. Garcia-Valdecasas,
J.J. Grau,
F. Novell,
E. Astudillo,
A. de Lacy,
M. Daniels,
A.M. Ballesta,
Preview
|
PDF (1803KB)
|
|
摘要:
The serum levels of CA 19-9 were determined in the follow-up of 370 patients with colorectal cancer and compared with CEA. An increase in CA 19-9 preceded clinical diagnosis of recurrence in 25% of 72 patients. The mean time between the rise in CA 19-9 and clinical diagnosis of relapse was 3.7 months (median 3). Sensitivity of CA 19-9 in the early diagnosis of recurrence was much lower than that obtained for CEA (75%). Only 1 patient had elevated CA 19-9 levels and normal CEA.
ISSN:1010-4283
DOI:10.1159/000217867
出版商:S. Karger AG
年代:1994
数据来源: Karger
|
2. |
Characterization of Nicotinamide Methyltransferase in Livers of Mice Bearing Ehrlich Ascites Tumors: Preferential Increase of Activity |
|
Tumor Biology,
Volume 15,
Issue 1,
1994,
Page 7-16
Yasuo Hanazawa,
Kenichi Sato,
Namiko Kuroiwa,
Masako Ogawa,
Atsuko Kuriyama,
Mineko Asanagi,
Noriko Kato,
Yoichi Moriyama,
Keisuke Horitsu,
Shinji Fujimura,
Preview
|
PDF (1725KB)
|
|
摘要:
There was a 2- to 7-fold increase in nicotinamide methyltransferase activity in the livers of mice and rats bearing seven different kinds of tumors compared with the respective control normal livers, while activity in the tumors themselves was hardly detectable. The activity in the liver started to increase markedly 3-7 days after i.p. transplantation of Ehrlich ascites tumors into the mice, maintaining a plateau up to death. Metabolic conversion of 14C-nicotinamide to 14C-N1methylnicotinamide was 3-fold higher in the slices of the ascites tumor host liver than in the normal liver, but the conversion to other radioactive metabolites was not significantly different. Nicotinamide methyltransferase was finally purified 20,000-fold with a yield of 4% from the cytosolic fraction of the ascites tumor host liver by means of five purification steps. At every purification step, only one enzyme fraction was detected. The enzyme finally isolated exhibited a single protein band in sodium dodecyl sulfate-polyacrylamide gel electrophoresis, with a molecular weight of 26,000. As for the compounds investigated, including the substrates for methyltransferases other than nicotinamide methyltransferase, only quinoline could be the substrate for enzyme activity. It is suggested that the increase in enzyme activity in the tumor host liver probably derived from the endogenous enzyme preexisting in the liver before tumor transplantation.
ISSN:1010-4283
DOI:10.1159/000217868
出版商:S. Karger AG
年代:1994
数据来源: Karger
|
3. |
Increased Plasma Concentrations for Type I and II Tumor Necrosis Factor Receptors and IL-2 Receptors in Cancer Patients |
|
Tumor Biology,
Volume 15,
Issue 1,
1994,
Page 17-24
U. Elsässer-Beile,
H. Gallati,
W. Weber,
E.D. Wild,
J. Schulte Mönting,
S. von Kleist,
Preview
|
PDF (2479KB)
|
|
摘要:
Using enzyme-linked immunoabsorbent assays for the soluble tumor necrosis factor (TNF) receptors type I (p55) and type II (p75) and IL·2 receptor we determined their levels in the plasma of 378 patients with various solid carcinomas, 56 patients with benign tumors, and 241 healthy controls. The plasma concentrations of both TNF receptors as well as the IL-2 receptor were significantly higher in the cancer patients than in the healthy controls, independent of the origin or histology of the tumor. The incidence and the extent of the receptor increase correlated with the extent of the disease. In the patients with benign tumors plasma levels of TNF receptor p75 and IL·2 receptor were not significantly different from the control
ISSN:1010-4283
DOI:10.1159/000217869
出版商:S. Karger AG
年代:1994
数据来源: Karger
|
4. |
Aryl Hydrocarbon Hydroxylase Activity in Spontaneous Mammary Tumors in Rat |
|
Tumor Biology,
Volume 15,
Issue 1,
1994,
Page 25-32
Kaija Pyykkö,
Ulla-Marjut Jaakkola,
Karl-Ove Söderström,
Sirpa Lamminen,
Preview
|
PDF (2656KB)
|
|
摘要:
The development of spontaneous mammary tumors was observed for about 2 years in a group of 25 female Sprague-Daw-ley rats aged over 1 year at the beginning of the study. All younger females in our animal facility were similarly monitored. In old females, the incidence of spontaneous mammary tumors was 64%. The parity of rats did not protect them from tumorigenesis, but the proportion of malignant tumors was higher in virgin (57%) than in parous (13%) rats. Activities of cytochrome P450IAI -dependent enzyme (aryl hydrocarbon hydroxylase, AHH) and NADPH-cytochrome P450 reductase (NCR) were determined in microsome fractions isolated from livers, lungs, uteri and tumors of rats. AHH and NCR activities in tumors and uteri were low compared to those in livers or lungs. In tumors, the activity distributions were wide, even in different tumors of the same animal the AHH activities varied as widely as between different animals. The activities in benign and malignant tumors were not statistically significantly different. No correlation with liver, lung or uterine activities was found either. With ageing of the rat, the AHH activities in tumors, liver and lungs decreased. The behavior of AHH in spontaneous mammary tumors in rats seems to be similar to that found in chemically induced tumors and seems to show individual regulation, possibly altered by tumorigenesis in each individual tumor.
ISSN:1010-4283
DOI:10.1159/000217870
出版商:S. Karger AG
年代:1994
数据来源: Karger
|
5. |
Factors Effecting the Measurement of Tumor-Associated MUC1 Mucins in Serum |
|
Tumor Biology,
Volume 15,
Issue 1,
1994,
Page 33-44
Michael A. McGuckin,
Peter L. Devine,
Louise E. Ramm,
Bruce G. Ward,
Preview
|
PDF (1798KB)
|
|
摘要:
MUCl epithelial mucins are produced by both normal and malignant epithelial cells. Serum proteins reactive with monoclonal antibodies against MUCl mucins were studied using several techniques. Separation of proteins by native PAGE showed that anti-MUC1 core protein antibodies reacted with a high Mr mucin but also with a 70-kD protein (p70) in normal women and women with ovarian cancer. After purification by gel filtration, p70 was not reactive in a double-determinant ELISA (CASA) and only weakly reactive in an inhibition assay. Serum CASA levels increased during pregnancy but p70 disappeared. Neuraminidase treatment of serum resulted in a greater increase in CASA in normal women and in ovarian cancer patients with low initial CASA than in ovarian cancer patients with high CASA and pregnant women (p < 0.05). These findings suggest that pregnancy and ovarian cancer-derived mucins are less heavily sialylated than mucin derived from normal tissues. An inhibition assay was developed which was more sensitive, but provided no diagnostic advantage over CASA. MUC1 is present in the serum of all women, reactivity in assays utilizing core protein antibodies is probably dependent not only on molar concentration but on the degree of exposure of peptide epitopes.
ISSN:1010-4283
DOI:10.1159/000217871
出版商:S. Karger AG
年代:1994
数据来源: Karger
|
6. |
Combined Use of Serum Enzyme Levels as Tumor Markers in Cervical Carcinoma Patients |
|
Tumor Biology,
Volume 15,
Issue 1,
1994,
Page 45-51
Prabhudas S. Patel,
Gira N. Rawal,
Damodar B. Balar,
Preview
|
PDF (2284KB)
|
|
摘要:
Enzymology has acquired a prominent place in human pathology, and serum enzyme investigations have become a prerequisite for various diseases, including cancer. Serum phosphohexose isomerase (PHI), aldolase (ALD) and alkaline phosphatase (ALP) levels were evaluated in 90 untreated patients with cervical carcinoma and 84 healthy age-matched females (controls). The concentrations of the three enzymes were significantly raised (p < 0.001) in patients compared to the controls. Receiver operating characteristic curve analysis revealed higher sensitivities of PHI and ALP, as compared to ALD at different specificity levels between 60 and 95%. Combined use of PHI and ALP revealed increased sensitivity and specificity. Combined use of PHI, ALD and ALP revealed a greater number of responders with enzyme values within the normal range than nonresponders. The results suggest that combined evaluation of the enzymes might be helpful to establish a useful aid to strengthen the armamentarium currently employed in the diagnosis and treatment monitoring of patients with cervical carcinoma.
ISSN:1010-4283
DOI:10.1159/000217872
出版商:S. Karger AG
年代:1994
数据来源: Karger
|
7. |
Diagnostic Value of Tissue Polypeptide Specific Antigen in Patients with Pancreatic Carcinoma |
|
Tumor Biology,
Volume 15,
Issue 1,
1994,
Page 52-60
Pentti A. Pasanen,
Matti Eskelinen,
Kaarina Partanen,
Pekka Pikkarainen,
Ilkka Penttilä,
Esko Alhava,
Preview
|
PDF (2913KB)
|
|
摘要:
We evaluated the clinical utility of a new tumor marker tissue polypeptide specific antigen (TPS) in the diagnosis of pancreatic carcinoma. Serum concentrations were determined in 113 patients with jaundice, in 18 patients with laboratory values suggesting cholestasis and in 60 patients with suspicion of chronic pancreatitis or pancreatic tumor. Twenty-four of these 191 patients had pancreatic carcinoma and 2 patients had carcinoma of the papilla of Vater. The highest median serum TPS value was detected in patients with malignant liver disease, but high median values were also measured in patients with pancreatic cancer, bile duct cancer or benign liver disease. The sensitivity of TPS was 50.0%, with a specificity of 73% and an efficiency of 70%. In comparison with carcinoembryonic antigen (CEA), CA 50 and CA 242, the TPS test showed lower sensitivity, but the differences in specificity and negative predictive value were considerably smaller. The utility of TPS as a complementary test was also analyzed. When TPS was combined with other marker tests, their specificities clearly improved, being highest in the combination of TPS and CA 242 (92.5%). In this combination, efficiency and positive likelihood ratio were also clearly better (85% and 5.6) than those of the marker tests alone. In conclusion, TPS seems less accurate than CEA, CA 50 or CA 242 in the diagnosis of pancreatic cancer, but because of its different nature it may be considered to be used as a complementary test.
ISSN:1010-4283
DOI:10.1159/000217873
出版商:S. Karger AG
年代:1994
数据来源: Karger
|
8. |
Announcement |
|
Tumor Biology,
Volume 15,
Issue 1,
1994,
Page 60-60
Preview
|
PDF (321KB)
|
|
ISSN:1010-4283
DOI:10.1159/000217874
出版商:S. Karger AG
年代:1994
数据来源: Karger
|
9. |
Newsletter |
|
Tumor Biology,
Volume 15,
Issue 1,
1994,
Page 61-62
Preview
|
PDF (559KB)
|
|
ISSN:1010-4283
DOI:10.1159/000217875
出版商:S. Karger AG
年代:1994
数据来源: Karger
|
|